Business Update
Chromos expands its board of directors
Published in Gene Therapy Weekly, December 28th, 2006
"We are very pleased to welcome Mr. Barr to Chromos' board of directors," said Darrell Elliott, chairman and director of Chromos. "David's extensive experience in helping companies achieve their potential, will bring immediate value to strategic planning at the board level."
Barr is currently the CFO and investment manager of PenderFund Capital Management Ltd. PenderFund is a shareholder of Chromos and a participant in the recent bridge loan financing. "I look forward to working with management in achieving the company's strategic goals...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-12-28)
More Articles from Gene Therapy Weekly
- Chronic Lymphocytic Leukemia
Lentigen wins U.S. NIH grant to develop a potential new therapy for CLL - Sexual & Reproductive Health
Gene therapy for erectile dysfunction shows promise in clinical trial - Breast Cancer Therapy
University of Lubeck details research in breast cancer therapy - Cancer Gene Therapy
Investigators at University of Colorado, Colorado Cancer Center have published new data on cancer gene therapy - Cancer Gene Therapy
Korea Institute of Radiological and Medical Science details research in cancer gene therapy - Cancer Gene Therapy
New cancer gene therapy research from Georgetown University, Lombardi Comprehensive Cancer Center outlined - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
